$8.09
-0.22-2.65%
Dern. MÀJ: Oct 16, 5:01 PM
$8.25
-0.06-0.72%
Harvard Bioscience (HBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2026) a publié ses dernières prévisions le $89.15M - $90.88M pour Harvard Bioscience {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
Par rapport aux prévisions précédentes, {{newestDate}} {{directionSummary}} ses prévisions de chiffre d'affaires ont été revues à la baisse, passant d'une fourchette précédente de undefined à undefined.
undefined a publié undefined mises à jour de ses recommandations entre undefined et undefined. undefined
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.15 | $-0.03 | $0.30 | $0.10 |
| Actual | $-0.14 | $-0.33 | $0.00 | $0.00 |
| Surprise | +6.67% | -1000.0% | -100.0% | -100.0% |
| Revenue | ||||
| Estimate | $21.4M | $21.2M | $23.1M | $20.0M |
| Actual | $22.7M | $20.8M | $23.7M | $20.6M |
| Surprise | +5.95% | -2.10% | +2.75% | +2.95% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.10 | $0.26 |
| Revenue | ||
| Consensus | $21.8M | $24.5M |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.14 | $-0.15 | 6.67 % |
| Q1 | May 12, 2026 | $-0.33 | $-0.03 | -1000.0 % |
| Q4 | Mar 12, 2026 | $0 | $0.30 | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $0.10 | -100.0 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $22.73M | $21.45M | 5.95 % |
| Q1 | May 12, 2026 | $20.76M | $21.20M | -2.10 % |
| Q4 | Mar 12, 2026 | $23.74M | $23.10M | 2.75 % |
| Q3 | Nov 6, 2025 | $20.59M | $20.00M | 2.95 % |